180 Life Sciences Corp.

Historical 13F Holders

Symbol
ETHZ
CUSIP
68236V302
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 68236V302 since 12/18/2024, largest first.

Filer % of Class Filed
Elray Resources, Inc. 13D/A
52.8% 4/11/2025
Event 3/27/2025
Steadfast Capital Management LP 13G
7.3% 8/12/2025
Event 8/4/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (8)
Electric Capital Partners Frontier Master Fund, LP 13G
Amended under CUSIP 68236V401 on 8/14/2026
8.6% 10/2/2025
Event 8/4/2025
FF Consumer Growth II, LP 13G
Amended under CUSIP 68236V401 on 2/17/2026
7.5% 8/11/2025
Event 8/4/2025
Citadel Securities GP LLC 13G
Amended under CUSIP 68236V401 on 2/17/2026
5.3% 9/25/2025
Event 9/18/2025
Intracoastal Capital LLC 13G
4.99% 1/3/2025
Event 12/27/2024
Ayrton Capital LLC 13G/A
4.6% 5/14/2025
Event 3/31/2025
Blair Jordan 13D/A 1.5% 8/6/2025
Event 7/24/2025
Anthony Brian Goodman 13D/A
0% 8/18/2025
Event 7/27/2025
Amtrust Financial Services, Inc. 13G/A
0% 7/22/2025
Event 7/17/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 71 38.9 M $93.6 M
2025 Q2 12 35.0 k $32.9 k
2025 Q1 11 28.1 k $27.6 k
2024 Q4 13 460 k $837 k
2024 Q3 7 23.8 k $40.3 k
2024 Q2 9 7.07 k $11.6 k
2024 Q1 8 22.6 k $52.6 k